SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs announcement that Phase 3 REGAL topline results for its GPS leukemia treatment are expected in November, following the trials 80th event, is driving attention. Traders are debating whether the CEOs comments signal optimism and fueling short-squeeze or data-leak speculation, while skeptics note the results remain uncertain and the companys language is conditional.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupting Outlook, Teams, Copilot and other services is driving attention, with traders weighing business disruption and reputational risk against MSFTs relative share-price resilience. Some speculate about a cyberattack, but Microsoft cited unexpectedly unavailable servers; the outages broader financial impact remains uncertain.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below a widely watched support level has fueled concern about further downside, with traders pointing to leveraged liquidations as adding to the selling pressure. The community is split between expecting a deeper decline and viewing the drop as a buying opportunity or potential rebound.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel pushed its planned prostate-cancer BLA filing to mid-2027 amid FDA discussions and assay refinements, prompting sharp concern about regulatory execution and management credibility. Some traders view the issue as a technical CMC delay rather than a problem with the clinical data, while others see the lack of detail and longer timeline as a significant risk.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly results beat expectations and its full-year outlook rose, with strong networking and AI-infrastructure demand drawing attention. Traders are split over the muted, volatile share reaction, weighing the growth story against margin pressure and questions about whether hyperscaler spending will translate into durable demand.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00344323 USD and is down -3.76 over the last 24 hours. It is currently trading on 374 active market(s) with $9,367,766.11 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs continued weakness and underperformance are driving discussion, with traders debating whether broader crypto-market conditions explain the decline or whether slow adoption and perceived team focus on Janction/JCT are to blame. Some holders are buying dips and citing ecosystem development, while critics point to weak activity and lack of execution progress.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

IBIT is under pressure as Bitcoin sells off amid spot-ETF redemptions and leveraged liquidations, with some traders also citing hawkish rate expectations and potential selling tied to Strategys index removal. The community is split between dip buyers anticipating a rebound and bearish traders warning that broken support could mean further weakness.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits pending FDA decision on ivonescimab for EGFR-mutated lung cancer is driving a binary-event debate: bulls point to strong progression-free survival and improving overall-survival trends, while bears focus on the trial missing formal statistical significance for overall survival and the FDAs stated requirement. Traders are bracing for a sharp reaction, and speculation about a possible leak is disputed rather than confirmed.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is caught in a volatile AI-hardware selloff, with traders citing worries that data-center spending and server orders depend on heavily financed customer capex, alongside concerns about thin margins, memory costs and Intels warning on PC demand. Bulls argue the AI-server backlog and long-term infrastructure buildout remain intact and view the pullback as overdone, while bears question whether booked orders will translate into durable, profitable demand.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius shares sold off sharply after its quarterly report despite strong results, as traders focused on 2026 revenue guidance moving to the low end of the outlook because of capacity delays and sharply higher planned capital spending. Bears question execution, financing needs and cash burn, while bulls argue that strong AI demand, customer prepayments and long-term growth prospects remain intact.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
